Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
HRTX
KLRS
Add up to 3 more stocks
HRTX
Heron Therapeutics, Inc.
-10.35%
$0.33-0.04Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$62.78M
52W Range
$0.26 - $1.58
KLRS
Kalaris Therapeutics Inc
-6.01%
$2.66-0.17Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$58.06M
52W Range
$2.51 - $11.88
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 10.72 | 1.01 |
| P/S Ratio | 0.42 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 70.1% | 0.0% |
| Operating Margin | -7.2% | 0.0% |
| Net Margin | -22.5% | 0.0% |
| ROE | -492.9% | -76.8% |
| ROA | -13.5% | -44.5% |
| ROIC | -6.8% | -52.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.49 | 10.98 |
| Quick Ratio | 1.51 | 10.98 |
| Debt/Equity | 21.48 | 0.02 |
| Interest Coverage | N/A | -31.98 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.